Physician profile
Daniel D Hansen
NPI 1316325590
$4,001.75
in general payments reported to CMS, 2019-2025
39 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,285 · 2020: $302 · 2021: $70.28 · 2022: $154 · 2023: $979 · 2024: $623 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,119 · Long Term Medical Supply Or Device Loan: $71.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,118.88 |
| Long Term Medical Supply Or Device Loan | $71.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $711.79 | 2019-2020 | |
| International Life Sciences | $690.39 | 2023 | |
| Amniox Medical, INC. | $415.60 | 2019 | |
| Amgen INC. | $245.25 | 2024-2025 | Krystexxa |
| Stryker Corporation | $204.47 | 2019-2025 | Augment Injectable, Ortholoc 3di Crosscheck, N/A |
| Paratek Pharmaceuticals, INC. | $173.63 | 2022-2025 | Nuzyra |
| Orthofix Medical, INC. | $173.30 | 2023-2025 | Physio-Stim |
| Horizon Therapeutics Plc | $171.47 | 2019-2023 | Krystexxa |
| Bone Support INC. | $144.90 | 2025 | Ceramentbone Void Filler, Cerament G |
| Integra Lifesciences Corporation | $127.60 | 2023-2025 | Integra, Micromatrix, Integra Dermal Regeneration Template |
| Bioventus LLC | $110.33 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Acell, INC. | $55.35 | 2019-2020 | |
| Kci USA, INC. | $50.91 | 2019-2023 | Kerramax Care, Activ.A.C. |
| Treace Medical Concepts, INC. | $50.76 | 2024-2025 | |
| Mimedx Group, INC. | $50.45 | 2024-2025 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.